Kimberly Stegmaier , MD
|
Office Phone: 617-632-4985
Appointment Line: 1-888-PEDI-ONC (733-4662)
Fax: 617-632-4850
NPI: 1801864202 |
Departments/Divisions
Specialties
cancer genomics
hematology/oncology
Services/Programs
Academic Appointments
Assistant Professor of Pediatrics, Harvard Medical School
Certifications
Pediatric Hematology/Oncology
Medical School
Harvard Medical School
Residencies
Pediatrics, Boston Combined Residency Program, Children's Hospital Boston/Boston Medical Center, Boston, MA
Pediatrics, Children's Hospital Boston, Boston, MA
Fellowship
Pediatric Hematology/Oncology, Children's Hospital Boston/Dana-Farber Cancer Institute, Boston, MA
Publications
Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D, Wright WD, Lessnick SL, Kung AL, Golub TR
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in ewing sarcoma
, 2007
PLoS Medicine
Issue: 4(4):e122
, Page: 0702-0714
Hahn CK, Ross KN, Warrington IM, Mazitschek R, Kanegai CM, Wright RD, Kung AL, Golub TR, Stegmaier K
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation
, 2008
Proc Natl Acad Sci U S A
Issue: 105(28)
, Page: 9751-9756
Cancer Genomics, "Signature-based Approaches to Cancer Therapy Discovery"
- Use of expression profiling and mass spectroscopy to screen for small molecules that induce differentiation of AML cells (Nature Genetics 36:257, 2004)
- Gefitinib differentiates AML blasts and is a potential therapeutic agent (Blood 106:2841, 2005)
Doctor Stegmaier's Research website
www.childrenshospital.org/cfapps/research/data_admin/Site2250/mainpageS2250P0.html
-
Dana-Farber Cancer InstituteDepartment of Pediatric Oncology450 Brookline AveBoston, MA 02215Phone: 617-632-4985Fax: 617-632-4850